McLaughlin Matthew F, Rosser Mica, Song Siyou, Mehta Nina, Terry Michael J, Kim Esther A
From the School of Medicine, University of California, San Francisco, San Francisco, Calif.
Division of Plastic and Reconstructive Surgery, University of California, San Francisco, San Francisco, Calif.
Plast Reconstr Surg Glob Open. 2024 Jul 15;12(7):e5972. doi: 10.1097/GOX.0000000000005972. eCollection 2024 Jul.
Research on the diverse patient population undergoing gender-affirming breast augmentation remains scarce. We compared patients undergoing this procedure at San Francisco General Hospital (ZSFG), a county hospital, and the University of California, San Francisco (UCSF), an academic medical center.
This was a retrospective cohort study of patients who underwent primary gender-affirming breast augmentation at ZSFG (August 2019 to June 2023) and UCSF (March 2015 to June 2023). Differences in sociodemographic characteristics, surgical access, and outcomes between sites were assessed.
Of 195 patients, 122 patients had surgery at UCSF and 73 patients at ZSFG. ZSFG patients were more likely to be unstably housed ( < 0.001), Spanish-speaking ( = 0.001), and to have obesity ( = 0.011) and HIV ( = 0.004). Patients at ZSFG took hormones for longer before surgical consultation ( < 0.001) but had shorter referral-to-surgery intervals ( = 0.024). Patients at ZSFG more frequently underwent a subglandular approach ( = 0.003) with longer operative times ( < 0.001). Major surgical complications were uncommon (2.1%) with no differences between sites. Aesthetically, implant malposition/rotation occurred more often in patients at UCSF ( = 0.031), but revision rates were similar at both sites. Patients at UCSF had longer follow-up periods ( = 0.008).
County hospital patients seeking gender-affirming breast augmentation have distinct sociodemographic profiles and more comorbidities than academic medical center patients. County patients might experience greater barriers that delay surgical eligibility, such as stable housing. Nevertheless, this procedure can be safely and effectively performed in both patient populations.
关于接受性别肯定性隆胸手术的不同患者群体的研究仍然很少。我们比较了在县医院旧金山总医院(ZSFG)和学术医疗中心加州大学旧金山分校(UCSF)接受该手术的患者。
这是一项对在ZSFG(2019年8月至2023年6月)和UCSF(2015年3月至2023年6月)接受初次性别肯定性隆胸手术的患者进行的回顾性队列研究。评估了不同地点之间社会人口学特征、手术入路和结局的差异。
在195例患者中,122例在UCSF接受手术,73例在ZSFG接受手术。ZSFG的患者更有可能居住不稳定(<0.001)、说西班牙语(=0.001),并且患有肥胖症(=0.011)和艾滋病毒(=0.004)。ZSFG的患者在手术咨询前服用激素的时间更长(<0.001),但从转诊到手术的间隔时间更短(=0.024)。ZSFG的患者更频繁地采用腺体下入路(=0.003),手术时间更长(<0.001)。主要手术并发症并不常见(2.1%),不同地点之间没有差异。在美学方面,UCSF的患者植入物位置不当/旋转的情况更常见(=0.031),但两个地点的修复率相似。UCSF的患者随访期更长(=0.008)。
寻求性别肯定性隆胸手术的县医院患者与学术医疗中心患者相比,具有不同的社会人口学特征和更多的合并症。县医院的患者可能会遇到更大的障碍,导致手术资格延迟,比如稳定的住房。然而,这一手术在这两类患者群体中都可以安全有效地进行。